Patient-Friendly Explanation

Oral GLP-1 receptor agonists are weight loss and diabetes medications that contain the same active ingredients as injections but are taken as a daily pill. They work by reducing appetite and slowing digestion, helping patients eat less. One example is oral semaglutide, taken once a day with water on an empty stomach.

Clinical Definition

Oral GLP-1 receptor agonists deliver GLP-1 receptor agonist therapy via a daily tablet formulation, with absorption enhanced by the co-administered absorption enhancer SNAC (salcaprozate sodium). Oral semaglutide demonstrates dose-dependent weight loss of approximately 5 to 15% of body weight over 68 weeks in clinical trials, with a gastrointestinal adverse-effect profile similar to injectable formulations. Bioavailability is reduced by food, requiring administration on an empty stomach.

Why It Matters

Offering oral options makes medical weight loss more acceptable to patients who are uncomfortable with injections, a decision point discussed during NuLifeCare consultations.